114 related articles for article (PubMed ID: 2403366)
1. Inhibition of angiotensin converting enzyme by L-alanyl-4 or 5-substituted-L-prolines and their N alpha-phosphoryl-derivatives.
Alexandrou EN; Liakopoulou-Kyriakides M
Biochem Int; 1990; 21(2):271-8. PubMed ID: 2403366
[TBL] [Abstract][Full Text] [Related]
2. N alpha-(diphenoxyphosphoryl)-L-alanyl-L-proline, N alpha-[bis (4-nitrophenoxy)phosphoryl]-L-alanyl-L-proline, and N alpha-[ (2-phenylethyl)phenoxyphosphoryl]-L-alanyl-L-proline: releasers of potent inhibitors of angiotensin converting enzyme at physiological pH and temperature.
Galardy RE; Grobelny D
J Med Chem; 1985 Oct; 28(10):1422-7. PubMed ID: 2995664
[TBL] [Abstract][Full Text] [Related]
3. Structure-activity relationship study between Ornithyl-Proline and Lysyl-Proline based tripeptidomimics as angiotensin-converting enzyme inhibitors.
Pavar MC; Hanif K; Azam A; Lata S; Qadar Pasha MA; Pasha S
Bioorg Med Chem Lett; 2006 Apr; 16(8):2117-21. PubMed ID: 16464585
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and biological evaluation of proline derivatives as potential angiotensin converting enzyme inhibitor.
Giugliano G; Grieco P; Ialenti A; Mottola M; Perissutti E; Santagada V
Boll Soc Ital Biol Sper; 1996; 72(1-2):29-36. PubMed ID: 8868112
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and angiotensin converting enzyme inhibitory activity of N-carboxymethyldipeptides with an omega-aminoalkyl group.
Saito S; Matsui S; Watanabe M; Waga T; Kajiwara Y; Shirota M; Iijima M; Kitabatake K
Arzneimittelforschung; 1990 Mar; 40(3):257-60. PubMed ID: 2346534
[TBL] [Abstract][Full Text] [Related]
6. (Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme. 2. Terminal amino acid analogues of (S)-1-[6-amino-2 [[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L-proline.
Karanewsky DS; Badia MC; Cushman DW; DeForrest JM; Dejneka T; Lee VG; Loots MJ; Petrillo EW
J Med Chem; 1990 May; 33(5):1459-69. PubMed ID: 2329568
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of angiotensin converting enzyme by 2-[N-[(S)-1-carboxy-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2-azabicyclo [3.3.0]octane-3-carboxylic acid (Hoe 498 diacid). Comparison with captopril and enalaprilat.
Bünning P
Arzneimittelforschung; 1984; 34(10B):1406-10. PubMed ID: 6097266
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of angiotensin-converting enzyme by dipeptide analogs.
Schwab A; Macerata R; Rogers W; Barton J; Skiles J; Khandwala A
Res Commun Chem Pathol Pharmacol; 1984 Sep; 45(3):339-45. PubMed ID: 6095384
[TBL] [Abstract][Full Text] [Related]
9. [Inhibition of the angiotensin-converting enzyme from bovine kidney by organophosphorus analogs of amino acids].
Shumiantseva VV; Gandurina IA; Osipova TI; Kugaevskaia EV
Vopr Med Khim; 1990; 36(4):74-6. PubMed ID: 2238538
[TBL] [Abstract][Full Text] [Related]
10. Bradykinin analogs as inhibitors of angiotensin-converting enzyme.
Chaturvedi D; Huelar E; Gunthorpe M; Gofman M; Krapf DS; Apostol E; Lewis WS
Pept Res; 1993; 6(6):308-12. PubMed ID: 8292848
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin converting enzyme inhibitory activity of amino acid esters of carbohydrates.
Kamath V; Rajini PS; Lohith K; Somashekar BR; Divakar S
Int J Biol Macromol; 2006 Mar; 38(2):89-93. PubMed ID: 16529809
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of angiotensin converting enzyme by phosphoramidates and polyphosphates.
Galardy RE
Biochemistry; 1982 Nov; 21(23):5777-81. PubMed ID: 6295438
[TBL] [Abstract][Full Text] [Related]
13. Uptake of N-[1 (S)-carboxy-(4-OH-3-125I-phenyl)ethyl]-L-Ala-L-Pro, an inhibitor of angiotensin-converting enzyme by rabbit lungs in situ.
Turrin M; Pitt BR; Ryan JW; Chung AY; Clark MB; Gillis CN
J Pharmacol Exp Ther; 1986 Jul; 238(1):14-8. PubMed ID: 3014113
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of angiotensin converting enzyme with N alpha-phosphoryl-L-alanyl-L-proline and N alpha-L-valyl-L-tryptophan.
Galardy RE
Biochem Biophys Res Commun; 1980 Nov; 97(1):94-9. PubMed ID: 6257245
[No Abstract] [Full Text] [Related]
15. Novel 3-amino-2-hydroxy acids containing protease inhibitors. Part 1: Synthesis and kinetic characterization as aminopeptidase P inhibitors.
Stöckel-Maschek A; Stiebitz B; Koelsch R; Neubert K
Bioorg Med Chem; 2005 Aug; 13(16):4806-20. PubMed ID: 15993089
[TBL] [Abstract][Full Text] [Related]
16. Antihypertensive agents: angiotensin converting enzyme inhibitors. 1-[3-(Acylthio)-3-aroylpropionyl]-L-prolines.
McEvoy FJ; Lai FM; Albright JD
J Med Chem; 1983 Mar; 26(3):381-93. PubMed ID: 6298428
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of rabbit lung angiotensin-converting enzyme by N alpha-[(S)-1-carboxy-3-phenylpropyl]L-alanyl-L-proline and N alpha-[(S)-1-carboxy-3-phenylpropyl]L-lysyl-L-proline.
Bull HG; Thornberry NA; Cordes MH; Patchett AA; Cordes EH
J Biol Chem; 1985 Mar; 260(5):2952-62. PubMed ID: 2982845
[TBL] [Abstract][Full Text] [Related]
18. General pharmacology of the non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
Shirota M; Hayashi M; Kajiwara Y; Kitabatake K; Uruno T; Kubota K
Arzneimittelforschung; 1993 Nov; 43(11):1169-74. PubMed ID: 8292059
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and angiotension converting enzyme inhibitory activity of L-lysyl-N-substituted glycine derivatives.
Saito S; Matsui S; Fukushima S; Watanabe M; Waga T; Kajiwara Y; Shirota M; Iijima M; Kitabatake K
Arzneimittelforschung; 1989 Dec; 39(12):1558-61. PubMed ID: 2560371
[TBL] [Abstract][Full Text] [Related]
20. Transport of pharmacologically active proline derivatives by the human proton-coupled amino acid transporter hPAT1.
Metzner L; Kalbitz J; Brandsch M
J Pharmacol Exp Ther; 2004 Apr; 309(1):28-35. PubMed ID: 14718599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
